SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-110389
Filing Date
2024-09-30
Accepted
2024-09-30 16:30:27
Documents
11
Period of Report
2024-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K caba-20240930.htm   iXBRL 8-K 42042
  Complete submission text file 0000950170-24-110389.txt   163285

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20240930.xsd EX-101.SCH 26988
13 EXTRACTED XBRL INSTANCE DOCUMENT caba-20240930_htm.xml XML 5115
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 241339864
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)